Gyre Therapeutics
GYRE
#4874
Rank
$1.49 B
Marketcap
$16.01
Share price
-4.70%
Change (1 day)
77.89%
Change (1 year)

Revenue for Gyre Therapeutics (GYRE)

Revenue in 2024 (TTM): $85.35 Million USD

According to Gyre Therapeutics's latest financial reports the company's current revenue (TTM ) is $85.35 Million USD. In 2023 the company made a revenue of $0.11 Billion USD an increase over the revenue in the year 2022 that were of $14.83 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Gyre Therapeutics from 2021 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) $85.35 M-24.76%
2023 $0.11 B664.94%
2022 $14.83 M5.49%
2021$14.05 M